scholarly article | Q13442814 |
P50 | author | Anna M. Blom | Q40406984 |
Markus S Huber-Lang | Q59692242 | ||
Daniel Rittirsch | Q65767068 | ||
P2093 | author name string | Gregory L Stahl | |
Lorenz Lampl | |||
Florian Gebhard | |||
Mario Perl | |||
Matthias Helm | |||
Michael A Flierl | |||
Myriam Martin | |||
Uwe Bruckner | |||
Anne-Maud Burk | |||
P2860 | cites work | Complement activation following multiple injuries | Q68830216 |
Complement-mediated neutrophil activation in sepsis- and trauma-related adult respiratory distress syndrome. Clarification with radioaerosol lung scans | Q68926921 | ||
Early activation of humoral proteolytic systems in patients with multiple trauma | Q69639211 | ||
The early diagnosis of impending coagulopathies following surgery and multiple trauma | Q69826197 | ||
Anaphylatoxin Generation in Multisystem Organ Failure | Q70230328 | ||
Inflammatory mediators in relation to the development of multiple organ failure in patients after severe blunt trauma | Q72588639 | ||
Changes of the hemostatic network in critically ill patients--is there a difference between sepsis, trauma, and neurosurgery patients? | Q73524158 | ||
Complement activation in injured patients occurs immediately and is dependent on the severity of the trauma | Q77291319 | ||
Complement C5a in the sepsis syndrome--too much of a good thing? | Q78768010 | ||
The role of C5a in the innate immune response after experimental blunt chest trauma | Q80590467 | ||
Complement inhibitor C4b-binding protein interacts directly with small glycoproteins of the extracellular matrix | Q83207254 | ||
Early expression changes of complement regulatory proteins and C5A receptor (CD88) on leukocytes after multiple injury in humans | Q84801521 | ||
The danger model: a renewed sense of self | Q28214633 | ||
Volume replacement in trauma patients within the first 24 h and its impact on the interpretation of biochemical data | Q30621135 | ||
Detrimental effects of complement activation in hemorrhagic shock | Q31837606 | ||
A mutation in factor I that is associated with atypical hemolytic uremic syndrome does not affect the function of factor I in complement regulation | Q33373174 | ||
Immune dysfunction in trauma | Q33811345 | ||
Pathophysiology of polytrauma | Q34420726 | ||
Molecular intercommunication between the complement and coagulation systems | Q35067949 | ||
Ischaemia-reperfusion is an event triggered by immune complexes and complement | Q35597392 | ||
Inhibition of the alternative complement activation pathway in traumatic brain injury by a monoclonal anti-factor B antibody: a randomized placebo-controlled study in mice | Q35790611 | ||
The role of complement in danger sensing and transmission | Q36499763 | ||
Complement component C5a mediates hemorrhage-induced intestinal damage | Q37087719 | ||
Polytrauma--pathophysiology and management principles | Q37145914 | ||
Complement activation and inhibition: a delicate balance. | Q37368654 | ||
Activation of the complement system generates antibacterial peptides | Q37695583 | ||
Dependence on Vitamin K-dependent Protein S for Eukaryotic Cell Secretion of the β-Chain of C4b-binding Protein | Q39669869 | ||
Trauma fatalities: time and location of hospital deaths | Q39672552 | ||
Platelet-activating factor and kinin-dependent vascular leakage as a novel functional activity of the soluble terminal complement complex | Q40489320 | ||
Activation of the clotting system and complement after trauma. | Q41085403 | ||
Circulating complement proteins in multiple trauma patients--correlation with injury severity, development of sepsis, and outcome | Q42055224 | ||
Role of C5a in multiorgan failure during sepsis | Q43516359 | ||
The role of the complement system in the pathogenesis of multiple organ failure in shock | Q44394701 | ||
Chemokine activation within 24 hours after blunt accident trauma | Q44664214 | ||
Complement activation and plasma levels of C4b-binding protein in critical limb ischemia patients | Q44746430 | ||
Role of the alternative pathway in the early complement activation following major trauma | Q46258966 | ||
The priming effect of C5a on monocytes is predominantly mediated by the p38 MAPK pathway. | Q55266421 | ||
Generation of C5a in the absence of C3: a new complement activation pathway | Q58523865 | ||
Differential regulation of alpha and beta chains of C4b-binding protein during acute-phase response resulting in stable plasma levels of free anticoagulant protein S | Q61634639 | ||
Gut bacterial translocation via the portal vein: a clinical perspective with major torso trauma. | Q64931568 | ||
Generation of anaphylatoxin C3a in plasma and bronchoalveolar lavage fluid in trauma patients at risk for the adult respiratory distress syndrome | Q68090655 | ||
The terminal complement complex (sC5b-9) is not specifically associated with the development of the adult respiratory distress syndrome | Q68696765 | ||
P433 | issue | 4 | |
P304 | page(s) | 348-354 | |
P577 | publication date | 2012-04-01 | |
P1433 | published in | Shock | Q7499831 |
P1476 | title | Early complementopathy after multiple injuries in humans | |
P478 | volume | 37 |
Q37393792 | A novel C5a-neutralizing mirror-image (l-)aptamer prevents organ failure and improves survival in experimental sepsis |
Q91997783 | Activation and Impaired Tumor Necrosis Factor-α Production of Circulating Mucosal-Associated Invariant T Cells in Patients with Trauma |
Q26782817 | Addressing the Global Burden of Trauma in Major Surgery |
Q36306007 | An anticomplement agent that homes to the damaged brain and promotes recovery after traumatic brain injury in mice |
Q48502611 | Auxiliary activation of the complement system and its importance for the pathophysiology of clinical conditions |
Q37369569 | C5aR inhibition in the early inflammatory phase does not affect bone regeneration in a model of uneventful fracture healing |
Q47166296 | Cardiac Depression in Pigs after Multiple Trauma - Characterization of Posttraumatic Structural and Functional Alterations. |
Q89965602 | Complement Activation and Organ Damage After Trauma-Differential Immune Response Based on Surgical Treatment Strategy |
Q57492399 | Complement After Trauma: Suturing Innate and Adaptive Immunity |
Q90582635 | Complement and coagulation cascades in trauma |
Q33432423 | Complement in disease: a defence system turning offensive |
Q40506861 | Complement mediates a primed inflammatory response after traumatic lung injury |
Q33420624 | Complement, thrombotic microangiopathy and disseminated intravascular coagulation |
Q35538801 | Crucial role of IL1beta and C3a in the in vitro-response of multipotent mesenchymal stromal cells to inflammatory mediators of polytrauma |
Q90707412 | Damage-associated molecular patterns in trauma |
Q92463404 | Dehydroepiandrosterone: a potential therapeutic agent in the treatment and rehabilitation of the traumatically injured patient |
Q36215702 | Design of the Study of Tranexamic Acid during Air Medical Prehospital Transport (STAAMP) Trial: Addressing the Knowledge Gaps |
Q55354179 | Diet-Induced Obesity Affects Muscle Regeneration After Murine Blunt Muscle Trauma-A Broad Spectrum Analysis. |
Q64057615 | Early complementopathy predicts the outcomes of patients with trauma |
Q47108823 | Experimental blunt chest trauma-induced myocardial inflammation and alteration of gap-junction protein connexin 43. |
Q52309394 | Extracellular Vesicles: Packages Sent With Complement. |
Q50051479 | Human brain trauma severity is associated with lectin complement pathway activation |
Q37106682 | Immunomodulation in transfused trauma patients |
Q99594987 | Immunopathophysiology of trauma-related acute kidney injury |
Q33427877 | Improvement of prognostic performance in severely injured patients by integrated clinico-transcriptomics: a translational approach |
Q92001797 | Inflammatory response of mesenchymal stromal cells after in vivo exposure with selected trauma-related factors and polytrauma serum |
Q52366499 | Innate immune responses to trauma. |
Q26747314 | Mesenchymal Stem Cells after Polytrauma: Actor and Target |
Q49546184 | Mesenchymal stem cells in peripheral blood of severely injured patients |
Q42233347 | Mitochondria and the lectin pathway of complement |
Q64889881 | Neutrophil heterogeneity and its role in infectious complications after severe trauma. |
Q90414062 | Novel Resolution Mediators of Severe Systemic Inflammation |
Q26995283 | Pathogenesis of infection in surgical patients |
Q39022520 | Postinjury Inflammation and Organ Dysfunction |
Q57101626 | Protective Effects of the Complement Inhibitor Compstatin CP40 in Hemorrhagic Shock |
Q42240816 | Risk of infection and sepsis in severely injured patients related to single nucleotide polymorphisms in the lectin pathway |
Q38573594 | Role of Complement on Broken Surfaces After Trauma |
Q38074156 | Role of complement in multiorgan failure |
Q26748401 | Sterile post-traumatic immunosuppression |
Q96167094 | Surgical trauma-induced immunosuppression in cancer: Recent advances and the potential therapies |
Q33457151 | Taking the Blood Bank to the Field: The Design and Rationale of the Prehospital Air Medical Plasma (PAMPer) Trial |
Q64065263 | Targeting Complement Pathways in Polytrauma- and Sepsis-Induced Multiple-Organ Dysfunction |
Q58115660 | The multifaceted role of complement in kidney transplantation |
Q36509516 | The systemic immune response to trauma: an overview of pathophysiology and treatment |
Search more.